Pitavastatin is a novel ‘statin’ for the treatment of hypercholesterolaemia. The request for approval dossier was submitted by Kowa Pharmaceutical Europe (KPE) at the end of August 2008
Previously, the company announced that the US Phase II clinical trial had been suspended in order to investigate an incident of post-operative bleeding. This event met the stopping
The terms of the proposed offer were not disclosed but include a stock for stock exchange and the assumption of liabilities with a potential total deal value in
The Ring trial is a randomized, double-blind, placebo-controlled study evaluating approximately 200 patients with refractory gastrointestinal stromal tumors (GIST) in over 20 countries and 50 sites worldwide. Patients
The lawsuit is based upon an abbreviated new drug application (ANDA) filed by Barr requesting approval to market and sell a generic version of Oxytrol to be sold
Under the proposed agreement, RecoverCare will purchase products from Ivivi, who in return will be responsible for providing initial training and ongoing technical and warranty support. In addition,
Under the terms of the agreement, GlaxoSmithKline will exclusively promote Diastat and Diastat AcuDial to US physicians in 2009, with an option to extend the term by mutual
With the approved CE Mark for Uracyst already in place for the European market, Eczacibasi Ilac Pazarlama (EIP) has agreed to obtain all necessary regulatory approvals at its
The combination of the two businesses will take place by a share exchange and create a European company in the field of discovery and development of therapeutics for
The company has also appointed David DeMagistris as senior vice president of pharmaceutical sciences and Jean Silveri as senior vice president of general counsel. Prior to joining Cerulean,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.